Coronavirus Vaccine Doses

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres

India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.

Amid a surge in coronavirus cases in several countries, regulator Irdai has asked insurers to consider giving discount on renewal of general and health insurance policies to policyholders who have taken three shots of COVID-19 vaccine.

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.

India's COVID-19 tally climbed to 4,38,68,476 today with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.

With an aim to increase the uptake of the precautionary dose of COVID vaccine among the eligible adult population, 75 days - 'COVID Vaccination Amrit Mahotsava' commenced on Friday.

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free booster doses of COVID-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country.

So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose, news agency PTI reported.

In view of the evolving scientific evidence and global practices, the Union Health Ministry on Wednesday revised the duration between the second COVID vaccine dose and precautionary dose from the existing 9 months to 6 months.

Over three crore children in the age group of 12-14 years have been administered the first dose of the COVID-19 vaccine, said Union Health Minister Mansukh Mandaviya said on Tuesday.

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres

India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.

Amid a surge in coronavirus cases in several countries, regulator Irdai has asked insurers to consider giving discount on renewal of general and health insurance policies to policyholders who have taken three shots of COVID-19 vaccine.

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.

India's COVID-19 tally climbed to 4,38,68,476 today with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.

With an aim to increase the uptake of the precautionary dose of COVID vaccine among the eligible adult population, 75 days - 'COVID Vaccination Amrit Mahotsava' commenced on Friday.

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free booster doses of COVID-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country.

So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose, news agency PTI reported.

In view of the evolving scientific evidence and global practices, the Union Health Ministry on Wednesday revised the duration between the second COVID vaccine dose and precautionary dose from the existing 9 months to 6 months.

Over three crore children in the age group of 12-14 years have been administered the first dose of the COVID-19 vaccine, said Union Health Minister Mansukh Mandaviya said on Tuesday.